Guidance for market authorization requirements for COVID-19 drugs: Labelling and post-market requirements - Guidance for market authorization requirements for COVID-19 drugs: Labelling and post-market requirements
Additional Information
| Created | July 28, 2022 |
|---|---|
| Format | HTML |